SLE: the changing prognosis.

Ugarte, A; Ruiz-Irastorza, G

Ugarte, A; Ruiz-Irastorza, G.

Affiliation

Ugarte A; Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, Spain.
Ruiz-Irastorza G; Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, Spain r.irastorza@outlook.es.

Lupus ; 25(12): 1285-7, 2016 Oct.

Article in En | MEDLINE | ID: mdl-27307448

Subject(s)

Lupus Erythematosus, Systemic/diagnostic imaging; Humans; Immunosuppressive Agents/adverse effects; Immunosuppressive Agents/therapeutic use; Lupus Erythematosus, Systemic/drug therapy; Prognosis; Survival Analysis; Treatment Outcome

Key words

Antiphospholipid syndrome; nephritis; systemic lupus erythematosus; thrombosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lupus Erythematosus, Systemic Type of study: Prognostic_studies Limits: Humans Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2016 Document type: Article Affiliation country: Spain Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google